{"id":61261,"date":"2024-02-28T07:32:49","date_gmt":"2024-02-28T07:32:49","guid":{"rendered":"https:\/\/medsname.com\/vilano\/"},"modified":"2026-05-01T10:49:16","modified_gmt":"2026-05-01T10:49:16","slug":"vilano","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ro\/product\/vilano\/","title":{"rendered":"Vilano"},"content":{"rendered":"

<\/p>\n

\n

⚡ Quick Answer — What is Vilano?<\/h3>\n
\n

Vilano<\/strong> con\u021bine vilazodone 40 mg<\/strong> de la un produc\u0103tor certificat WHO-GMP (Lupin Pharmaceuticals) \u2014 un dual-mechanism antidepressant<\/strong>: SERT inhibition (SSRI) plus<\/em> 5-HT1A<\/sub> partial agonism. FDA-approved 2011 for MDD only<\/strong> (no anxiety or other indications). Standard target dose: 40 mg once daily with food<\/strong> (must be taken with at least 500 calories — bioavailability halves on an empty stomach). Titrate from 10 mg over 2 weeks to reduce GI side effects. Sexual side-effect rate is lower than other SSRIs<\/strong> — the 5-HT1A<\/sub> partial agonism is the proposed reason. Diarrhoea is the most common bothersome side effect. Onset 2–4 weeks; full response by 8 weeks.<\/p>\n<\/div>\n

\nCe beneficii ofer\u0103 MedsBase:<\/strong> Produc\u0103tor certificat WHO-GMP \u00b7 Ambalaj discret \u00b7 Livrare la nivel mondial \u00b7 Peste 1.400 de recenzii verificate ale clien\u021bilor<\/a>\n<\/div>\n

\ud83d\udce6 Fiecare comand\u0103 este acoperit\u0103 de politica noastr\u0103 de Politica noastr\u0103 de Reexpediere Garantat\u0103<\/strong><\/a> \u2014 dac\u0103 coletul dumneavoastr\u0103 nu sose\u0219te \u00een 20 de zile lucr\u0103toare, \u00eel relivr\u0103m.<\/p>\n

De ce s\u0103 comanzi de la MedsBase<\/h3>\n

Medicamentele noastre generice sunt procurate de la produc\u0103tori certifica\u021bi WHO-GMP \u0219i expediate la nivel mondial \u00een ambalaje discrete \u0219i simple \u2014 f\u0103r\u0103 denumirea medicamentului pe exteriorul coletului. Pl\u0103\u021bile cu cardul sunt procesate printr-un procesor reglementat (descrierile de pe extrasul de cont includ un procesor de pl\u0103\u021bi cu card reglementat \u2014 niciodat\u0103 \u201cMedsBase\u201d sau numele vreunui medicament). Accept\u0103m \u0219i criptomonede \u0219i transferuri bancare SEPA. Fiecare comand\u0103 este sus\u021binut\u0103 de Politica noastr\u0103 de Asigurare pentru Relivrare.<\/p>\n<\/div>\n

Important \u2014 acesta nu este un medicament pentru anxietate situa\u021bional\u0103.<\/strong> Vilano is a SSRI plus 5-HT1A partial agonist<\/strong>, prescris \u0219i titrat pe s\u0103pt\u0103m\u00e2ni pentru tulburare depresiv\u0103 major\u0103 (MDD)<\/strong>. Este prime\u0219te,<\/strong> medicamentul potrivit pentru anxietatea acut\u0103 legat\u0103 de performan\u021b\u0103 (zbor, vorbire \u00een public, examene) \u2014 pentru acele cazuri, beta-blocantele (propranolol), benzodiazepinele sau hidroxizina sunt op\u021biuni clinice adecvate. Dac\u0103 nu ave\u021bi o tulburare de dispozi\u021bie, anxietate sau psihiatric\u0103 diagnosticat\u0103, nu \u00eencepe\u021bi acest tratament.<\/div>\n
Avertizare FDA black-box \u2014 suicidalitate.<\/strong> Toate antidepresivele poart\u0103 un avertisment FDA \u00een cadru negru privind riscul crescut de g\u00e2nduri \u0219i comportament suicidare la copii, adolescen\u021bi \u0219i adul\u021bi tineri sub 25 de ani, \u00een special \u00een primele s\u0103pt\u0103m\u00e2ni de tratament sau dup\u0103 modific\u0103ri de doz\u0103. Membrii familiei \u0219i medicii prescriptori ar trebui s\u0103 monitorizeze \u00eendeaproape \u00eenr\u0103ut\u0103\u021birea st\u0103rii de spirit, agita\u021bia sau ideile suicidare \u00een aceast\u0103 grup\u0103 de v\u00e2rst\u0103.<\/div>\n

What Is Vilano?<\/h2>\n

Vilano is an oral tablet of vilazodone hydrochloride 40 mg<\/strong> manufactured by Lupin Pharmaceuticals. Vilazodone (US brand Viibryd<\/strong>) was FDA-approved in 2011 as a dual-mechanism antidepressant: it combines selective serotonin reuptake inhibition (SSRI) with 5-HT1A<\/sub> partial agonism<\/strong>, similar to the partial agonism of buspirone. The 5-HT1A<\/sub> partial agonism is proposed to reduce the sexual side-effect burden seen with classical SSRIs.<\/p>\n

Indica\u021bii aprobate<\/h2>\n